Zafrens

Zafrens Inc. has developed an ultra-high-throughput platform capable of isolating, culturing, imaging, and sequencing millions of cells daily. This proprietary platform enables comprehensive characterization of diverse cell populations and directly links molecular profiles (DNA, RNA, proteins) with cell phenotype and function. The company’s mission is to unlock the complete story of every cell to accelerate drug discovery.